It is established that TNF‐α, IL‐6, and IL‐1β are key proinflammatory cytokines involved in the onset of colitis,27 and IL‐10, an anti‐inflammatory cytokine, increases following Res administration in IBD patients.28 The gene discussed is IL1B; the disease is colitis.